Commission Implementing Regulation (EU) 2021/16 of 8 January 2021 laying down the necessary measures and practical arrangements for the Union database on veterinary medicinal products (Union product database)
Article 18Responsibilities for including, updating and sharing information
In force · version of Jan 31, 2021
1.As of 28 January 2022, competent authorities or the Commission, as applicable, shall, within 30 days of a positive outcome of the procedure for marketing authorisation in accordance with Chapter III of Regulation (EU) 2019/6, registration in accordance with Chapter V of Regulation (EU) 2019/6, permission to use in accordance with Article 5(6) of Regulation (EU) 2019/6 or approval for parallel trade in accordance with Article 102 of Regulation (EU) 2019/6, create new or provisional entries, as relevant, in the Union product database for products under their responsibility by providing to it data and documents submitted in electronic form to them by applicants. The relevant competent authority or the Commission, as applicable, shall update those entries with the assessment report, after deleting any commercially confidential information contained therein, as soon as it becomes available.
2.The Agency, in collaboration with the Member States and the Commission, shall ensure that business rules are defined and guidance is provided to facilitate data consistency between national systems and the Union product database.
3.Competent authorities, the Commission and the Agency shall ensure that the data entered into the Union product database conform to the format and specifications laid down in this Regulation.
4.The updates to the Union product database referred to in Article 67(4) of Regulation (EU) 2019/6 shall be made within 30 days of the completion of the procedure provided for in Article 67(1) of the same Regulation.
5.Marketing authorisation holders shall record any changes in the availability of each veterinary medicinal product in each relevant Member State as soon as they become aware of them.
6.Marketing authorisation holders shall record the dates of any suspension or revocation of the marketing authorisations concerned as soon as those changes occur. Where the marketing authorisation holder fails to fulfil this obligation within 30 days, the competent authorities or the Commission, as applicable, shall record and update this information. In case of disagreement, the competent authorities’ entries in the Union product database shall take precedence.
7.Competent authorities of the destination Member State shall be responsible for recording the necessary information on parallel-traded veterinary medicinal products under their responsibility.
8.Marketing authorisation holders shall be responsible for ensuring that the data and documents they record in datasets existing in the Union product database for their veterinary medicinal products are correct and up to date.
9.Where holders of a marketing authorisation granted in accordance with Chapter III of Regulation (EU) 2019/6, of a registration for homeopathic veterinary medicinal products granted in accordance with Chapter V of Regulation (EU) 2019/6, of veterinary medicinal products referred to in Article 5(6) of Regulation (EU) 2019/6 or of an approval to parallel trade veterinary medicinal products in accordance with Article 102 of Regulation (EU) 2019/6 identify data or document quality issues in the entries created for their veterinary medicinal products in accordance with paragraph (1), or updated in accordance paragraph (4), they shall immediately notify the relevant competent authorities or the Commission, as applicable, which shall correct the data without delay upon verification that the requests are justified.
10.The Agency shall ensure that the responsibilities laid down in this Article may be performed either by super users or controlled users or by systems external to the Union product database. The access of those systems to the Union product database shall be handled as if they were super users or controlled users.